QTRX Quanterix Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: QTRX

Price (delayed)

$3.82

Market cap

$179.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.34

Enterprise value

$175.75M

?
Relative Growth: Rel. Growth: 32
Relative Strength: Rel. Strength: 7
Relative Valuation: Rel. Valuation: 28
Relative Profitability: Rel. Profitability: 14

Quanterix is a company that's digitizing biomarker analysis with the goal of advancing the science of precision health. The company's digital health solution, Simoa, has the potential to change the ...

Highlights
The revenue has grown by 7% year-on-year and by 4.4% since the previous quarter
The debt has contracted by 5% from the previous quarter and by 2.9% YoY
QTRX's net income has dropped by 118% year-on-year but it is up by 2.8% since the previous quarter
Quanterix's EPS has shrunk by 89% YoY but it has increased by 7% QoQ
QTRX's gross margin is down by 24% year-on-year and by 6% since the previous quarter
The gross profit has declined by 19% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.quanterix.com
Peers: RVTY PRPO MTD

Key stats

What are the main financial stats of QTRX

QTRX stock price

How has the Quanterix stock price performed over time
Intraday
8.22%
1 week
25.25%
1 month
13.35%
1 year
-31.54%
YTD
-39.94%
QTD
8.52%

Financial performance

How have Quanterix's revenue and profit performed over time
Revenue
$144.98M
Gross profit
$64.11M
Operating income
-$140.54M
Net income
-$104.19M
Gross margin
44.2%
Net margin
-71.9%
The operating income has dropped by 120% year-on-year and by 12% since the previous quarter
QTRX's net income has dropped by 118% year-on-year but it is up by 2.8% since the previous quarter
Quanterix's operating margin has shrunk by 106% YoY and by 7% QoQ
The net margin has plunged by 104% YoY but it has grown by 7% from the previous quarter

Price vs fundamentals

How does QTRX's price correlate with its fundamentals

Growth

What is Quanterix's growth rate over time

Valuation

What is Quanterix stock price valuation
P/E
N/A
P/B
0.64
P/S
1.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.21
Quanterix's EPS has shrunk by 89% YoY but it has increased by 7% QoQ
The price to book (P/B) is 69% lower than the 5-year quarterly average of 1.9 and 26% lower than the last 4 quarters average of 0.8
The equity has contracted by 11% YoY and by 4.6% from the previous quarter
QTRX's price to sales (P/S) is 82% less than its 5-year quarterly average of 6.5 and 37% less than its last 4 quarters average of 1.8
The revenue has grown by 7% year-on-year and by 4.4% since the previous quarter

Efficiency

How efficient is Quanterix business performance
QTRX's ROE has shrunk by 144% YoY
The company's return on assets has shrunk by 122% YoY
Quanterix's return on sales has shrunk by 97% YoY but it has increased by 9% QoQ
The return on invested capital has declined by 9% since the previous quarter

Dividends

What is QTRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QTRX.

Financial health

How did Quanterix financials performed over time
QTRX's quick ratio has dropped by 65% year-on-year but it is up by 28% since the previous quarter
The current ratio has dropped by 55% year-on-year but it is up by 31% since the previous quarter
The debt is 87% less than the equity
The equity has contracted by 11% YoY and by 4.6% from the previous quarter
The debt to equity is up by 8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.